Webinar

Contents

Chair

Jean-François Dufour, MD

Director
Centre des maladies digestives, Lausanne, Switzerland.
Specialist in Internal Medicine, Gastroenterology and Hepatology.

Speaker(s)

Pompilia Radu, MD, PhD

Hepatology-Department of Biomedical Research, University of Bern, Bern, Switzerland; University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern, Bern, Switzerland.

Topic: What is the place of body composition assessment in HCC management?

Francesco Tovoli, MD, PhD

Senior assistant professor, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Topic: Shall we recommend coffee consumption to patients at risk of liver cancer?

Xuehong Zhang, MBBS, ScD

Assistant Professor in Medicine, Harvard Medical School; Assistant Professor in the Department of Nutrition, Harvard T. H. Chan School of Public Health; Associate Epidemiologist, Brigham and Women's Hospital; Co-Chair, Liver Cancer Task Force, Dana Farber Harvard Cancer Center.

Topic: Which diet shall we recommend to decrease the risk of HCC?

Jean-François Dufour, MD

Director
Centre des maladies digestives, Lausanne, Switzerland.
Specialist in Internal Medicine, Gastroenterology and Hepatology.

Topic: Is it worth to recommend physical activity to decrease HCC risk?

Iulia Minciuna

Regional Institute of Gastroenterology and Hepatology Octavian Fodor, Romania.

Topic: Is fasting good when one is at risk of liver cancer?
Programme
Programme
  1. Time (Switzerland, UTC +1)
  1. Speakers
  1. Topics
  1. 14:00-14:10
  1. Chair(Jean-Francois Dufour)
  1. Welcome Remarks
  1. 14:10-14:25
  1. Francesco Tovoli
  1. Shall we recommend coffee consumption to patients at risk of liver cancer?
  1. 14:25-14:40
  1. Iulia Minciuna
  1. Is fasting good when one is at risk of liver cancer?
  1. 14:40-14:55
  1. Xuehong Zhang
  1. Which diet shall we recommend to decrease the risk of HCC?
  1. 14:55-15:15
  1. /
  1. Discussion Part 1
  1. 15:15-15:25
  1. /
  1. Break
  1. 15:25-15:40
  1. Jean-Francois Dufour
  1. Is it worth to recommend physical activity to decrease HCC risk?
  1. 15:40-15:55
  1. Pompilia Radu
  1. What is the place of body composition assessment in HCC management?
  1. 15:55-16:15
  1. /
  1. Discussion Part 2
  1. 16:15-16:25
  1. Chair(Jean-Francois Dufour)
  1. Concluding Remarks

Moments

Presentation

Francesco Tovoli, Senior assistant professor, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Topic: Shall we recommend coffee consumption to patients at risk of liver cancer?

NaN

Iulia Minciuna, Regional Institute of Gastroenterology and Hepatology Octavian Fodor, Romania.
Topic: Is fasting good when one is at risk of liver cancer?

NaN

Xuehong Zhang, Assistant Professor in Medicine, Harvard Medical School; Assistant Professor in the Department of Nutrition, Harvard T. H. Chan School of Public Health; Associate Epidemiologist, Brigham and Women's Hospital; Co-Chair, Liver Cancer Task Force, Dana Farber Harvard Cancer Center.
Topic: Which diet shall we recommend to decrease the risk of HCC?

NaN

Jean-François Dufour, Director, Centre des maladies digestives, Lausanne, Switzerland. Specialist in Internal Medicine, Gastroenterology and Hepatology.
Topic: Is it worth to recommend physical activity to decrease HCC risk?

NaN

Pompilia Radu, Hepatology-Department of Biomedical Research, University of Bern, Bern, Switzerland; University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern, Bern, Switzerland.
Topic: What is the place of body composition assessment in HCC management?

NaN
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/